These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38436356)

  • 1. Phenotypic spectrum of inclusion body myositis.
    Roy B; Dimachkie MM; Naddaf E
    Clin Exp Rheumatol; 2024 Feb; 42(2):445-453. PubMed ID: 38436356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes.
    Alamr M; Pinto MV; Naddaf E
    Muscle Nerve; 2022 Dec; 66(6):686-693. PubMed ID: 36052422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two emerging phenotypes of atypical inclusion body myositis: illustrative cases.
    Salam S; Morrow JM; Howard R; Miller JAL; Quinlivan RM; Machado PM
    Clin Exp Rheumatol; 2023 Mar; 41(2):340-347. PubMed ID: 36861744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion body myositis: from genetics to clinical trials.
    Nagy S; Khan A; Machado PM; Houlden H
    J Neurol; 2023 Mar; 270(3):1787-1797. PubMed ID: 36399165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion body myositis: Update on the diagnostic and therapeutic landscape.
    Naddaf E
    Front Neurol; 2022; 13():1020113. PubMed ID: 36237625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion body myositis with early onset: a population-based study.
    Lindgren U; Hedberg-Oldfors C; Pullerits R; Lindberg C; Oldfors A
    J Neurol; 2023 Nov; 270(11):5483-5492. PubMed ID: 37498322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion-body myositis presenting with facial diplegia.
    Ghosh PS; Laughlin RS; Engel AG
    Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion Body Myositis.
    Goyal NA
    Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion body myositis: a case of bilateral extremity weakness.
    Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK
    Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the evaluation and management of dysphagia in sporadic inclusion body myositis.
    Garand KLF; Malandraki GA; Dimachkie MM
    Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):362-367. PubMed ID: 37678324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.
    Suwa Y; Suzuki N; Soga T; Harada R; Shibui A; Kuroda H; Izumi R; Tateyama M; Nakashima I; Sonoo M; Aoki M
    Intern Med; 2016; 55(23):3521-3524. PubMed ID: 27904121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients.
    Badrising UA; Maat-Schieman ML; van Houwelingen JC; van Doorn PA; van Duinen SG; van Engelen BG; Faber CG; Hoogendijk JE; de Jager AE; Koehler PJ; de Visser M; Verschuuren JJ; Wintzen AR
    J Neurol; 2005 Dec; 252(12):1448-54. PubMed ID: 15942703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of dysphagic inclusion body myositis.
    Taira K; Mori-Yoshimura M; Yamamoto T; Oya Y; Nishino I; Takahashi Y
    Neuromuscul Disord; 2023 Feb; 33(2):133-138. PubMed ID: 36575104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protocol to develop clinical guidelines for inclusion-body myositis.
    Jones KL; Sejersen T; Amato AA; Hilton-Jones D; Schmidt J; Wallace AC; Badrising UA; Rose MR;
    Muscle Nerve; 2016 Apr; 53(4):503-7. PubMed ID: 26800092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Face to Face: deciphering facial involvement in inclusion body myositis.
    Fortanier E; Delmont E; Kouton L; Corazza G; Grapperon AM; Verschueren A; Attarian S; Salort-Campana E
    J Neurol; 2024 Jan; 271(1):410-418. PubMed ID: 37740740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature.
    Chatterjee S; Prayson RA
    Semin Arthritis Rheum; 2020 Jun; 50(3):498-502. PubMed ID: 31806155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Semin Neurol; 2012 Jul; 32(3):237-45. PubMed ID: 23117948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.
    Michelle EH; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Tiniakou E; Adler B; Mecoli CA; Danoff SK; Christopher-Stine L; Mammen AL; Lloyd TE
    Neurology; 2023 Mar; 100(13):e1406-e1417. PubMed ID: 36690456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.